Your search returned 3 results.

Results
	1.	Understanding the biosimilar approval and extrapolation process-A case study of an epoetin biosimilar. [electronic resource] by Agarwal, Amit B McBride, Ali Producer: 20170112 In: Critical reviews in oncology/hematology vol. 104 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas. [electronic resource] by Friedberg, Jonathan W Mahadevan, Daruka Cebula, Erin Persky, Daniel Lossos, Izidore Agarwal, Amit B Jung, Jungah Burack, Richard Zhou, Xiaofei Leonard, E Jane Fingert, Howard Danaee, Hadi Bernstein, Steven H Producer: 20140228 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM. [electronic resource] by Moreau, Philippe Chanan-Khan, Asher Roberts, Andrew W Agarwal, Amit B Facon, Thierry Kumar, Shaji Touzeau, Cyrille Punnoose, Elizabeth A Cordero, Jaclyn Munasinghe, Wijith Jia, Jia Salem, Ahmed Hamed Freise, Kevin J Leverson, Joel D Enschede, Sari Heitner Ross, Jeremy A Maciag, Paulo C Verdugo, Maria Harrison, Simon J Producer: 20171218 In: Blood vol. 130 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)